Bibliografia UJ CM

1/4
G. Bianchi, E[dward] Czerwinski, A. Kenwright, A. Burdeska, R.R. Recker, D. Felsenberg.
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis : 5-year data from the DIVA study long-term extension.
Osteoporosis International
2012 : Vol. 23, nr 6, s. 1769-1778, il., bibliogr. 40 poz., abstr.
p-ISSN: 0937-941X
AZ
ORG
AIF
IF: 4.039
2/4
E[dward] Czerwinski, C. Strugala, A. Burdeska, J.A. Stakkestad.
Continued favourable renal tolerability with ibandronate intravenous injections in women with postmenopausal osteoporosis : the DIVA study LTE.
Annals of the Rheumatic Diseases
2008 : Vol. 67 suppl. 2, s. 404-405, abstr. FRIO386
Annual European Congress of Rheumatology EULAR 2008, Paris, 11-14 June 2008.
SZZ
SIF
3/4
L.B. Tanko, D. Felsenberg, E[dward] Czerwiński, A. Burdeska, I. Jonkanski, C. Hughes, C. Christiansen, The Oral Ibandronate Group.
Oral weekly ibandronate prevents bone lossin postmenopausal women.
Journal of Internal Medicine
2003 : Vol. 254, nr 2, s. 159-167, il., bibliogr. 18 poz.
AZ
ORG
AIF
IF: 3.250
Streszczenie w PubMed:
DOI:
4/4
D. Felsenberg, C. Christiansen, E[dward] Cerwinski, A. Burdeska, I. Jonkanski, R. Meinert, The Oral Ibandronate Study Group.
Weekly dosing of oral ibandronate is effective in the prevention of postmenopausal osteoporosis.
Osteoporosis International
2002 : Vol. 13 suppl. 1, s. S16, poster P42SU.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ